Table 7.
Serotype | Number | Percent |
---|---|---|
1 | 28 | 1.1 |
3 | 161 | 6.6 |
4∗ | 219 | 9.0 |
5 | 242 | 9.9 |
6A | 51 | 2.1 |
6B∗ | 42 | 1.7 |
7F | 129 | 5.3 |
9V∗ | 64 | 2.6 |
14∗ | 92 | 3.8 |
18C∗ | 39 | 1.6 |
19A | 113 | 4.6 |
19F∗ | 53 | 2.2 |
23F∗ | 45 | 1.8 |
2 | 1 | 0.04 |
8 | 193 | 7.9 |
9N | 65 | 2.7 |
10A | 17 | 0.7 |
11A | 80 | 3.3 |
12F | 70 | 2.9 |
15B | 15 | 0.6 |
17F | 27 | 1.1 |
20 | 93 | 3.8 |
22F | 176 | 7.2 |
32F | 0 | 0 |
33F | 45 | 1.8 |
16F | 33 | 1.4 |
23A | 39 | 1.6 |
23B | 30 | 1.2 |
16F | 33 | 1.4 |
The first 13 serotypes are in PCV-13 and first 23 in PPV-23. ∗ denotes serotypes in PCV-7. The final four serotypes represent the remaining serotypes that accounted for ≥1% of the isolates beyond those in the 23-valent vaccine.